New study aims to better understand meningioma Patients' quality of life
NCT ID NCT07376473
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a French questionnaire designed to measure quality of life in adults with meningioma, a type of brain tumor. About 238 participants will fill out online surveys about their well-being. No treatment or extra visits are involved—just questionnaires. The goal is to make sure the tool accurately captures how meningioma affects daily life.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 238 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Feb 2026
An estimate. Start dates often move.
- Expected to finish
-
Sep 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Adults with intracranial meningioma, recruited through three sources to maximize heterogeneity: (1) patients seen in consultation at GHU Paris-Sainte-Anne; (2) members of the AMAVEA patient association informed by email; and (3) patients proposed by partner teams after a call for participation within the French Society of Neurosurgery Neuro-Oncology Club and Skull Base Club, contacted by email and invited to complete online questionnaires via REDCap.
- Ages
-
18 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria : * Inclusion Criteria: * Age ≥ 18 years * Diagnosis of intracranial meningioma on imaging and/or confirmed by surgery Exclusion Criteria: * Pregnant or breastfeeding * Individuals deprived of liberty by judicial/administrative decision or under compulsory psychiatric care * Insufficient French language proficiency/comprehension * Unable to complete the questionnaires independently * Unable to express non-opposition to participation
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Health related quality of life are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Starving brain tumors of blood before surgery
- Brain tumor or aneurysm first? study weighs the safer sequence
- Can multiple radiation doses tame large brain tumors?
- Brain surgery safety: live signal monitoring may shield speech, movement, and sight
- Could blocking a Tumor's blood supply shrink brain meningiomas?
- New platform trial takes on NF2 tumors with multiple drug strategies